168
Views
2
CrossRef citations to date
0
Altmetric
CLINICAL TRIAL REPORT

Efficacy of Invariant Natural Killer T Cell Infusion Plus Transarterial Embolization vs Transarterial Embolization Alone for Hepatocellular Carcinoma Patients: A Phase 2 Randomized Clinical Trial

, , , ORCID Icon, , & show all
Pages 1379-1388 | Received 12 Apr 2023, Accepted 04 Aug 2023, Published online: 21 Aug 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.